HB 1735 expands New Hampshire's Right to Try Act to allow patients with "qualifying severe illness" (defined as chronic and debilitating conditions meeting federal standards) to access investigational treatments, in addition to those with terminal illnesses. The bill amends definitions to include this new category, requiring patients to have exhausted standard FDA-approved treatments and be unable to join clinical trials. It maintains existing requirements like physician oversight, patient consent, and no direct manufacturer compensation for providers. This change directly affects patients with severe chronic conditions who currently lack access to investigational therapies under state law. The bill does not alter cost-sharing or data collection requirements for manufacturers.
HB 1219 prevents foster family homes from imposing immunization requirements on children or foster parents that are stricter than those in RSA 141-C:20-a. Specifically, it prohibits requirements exceeding the standard for vaccine type, number of doses, or exemption policies already established for the general population. This bill directly affects foster children and foster parents by aligning their immunization standards with statewide requirements. The law amends RSA 170-E:27-b to ensure foster homes cannot mandate additional or more stringent vaccinations than what is required for children in public schools or the general community.
HB 1245 establishes a voluntary framework for independent contractors in New Hampshire to access portable benefits like health insurance, retirement plans, or disability coverage through designated providers. Hiring parties (businesses or platforms) can voluntarily contribute to these plans or withhold a portion of payment from the contractor, with the contractor’s written consent. Crucially, participation in these plans cannot be used to reclassify a worker as an employee under state law, preserving current independent contractor status. The bill requires clear opt-in agreements and has no estimated state or local cost impact.
HB 1323 defines "parental alienation" as a pattern of behavior damaging a child's relationship with a parent - such as disparaging remarks, manipulation, or unjustified interference with parenting time - while excluding protective actions taken in good faith for safety concerns. The bill requires New Hampshire courts to consider parental alienation as a factor in custody, visitation, and parental rights decisions, including joint decision-making and modifications to parenting plans. It establishes a "family access motion" for parents to seek enforcement of parenting plans when alienation occurs and allows courts to order remedies like adjusted schedules. The law also mandates courts to evaluate parental alienation in grandparent visitation cases and requires attorney fee awards in contempt cases involving failure to comply with court orders related to parental alienation.
SB 504 allows licensed healthcare providers to dispense up to a 30-day supply of certain cancer medications directly to patients under a doctor's supervision, requiring clinics to maintain a full-time pharmacist available for consultation. It removes the requirement for pharmacists' names on controlled drug labels and permits advanced pharmacy technicians to perform remote medication processing. The bill updates the definition of "practice of pharmacy" to include modern services like medication therapy management and collaborative care. These changes streamline access to cancer medications while maintaining safety protocols for pharmacy operations.
HB 1378 would require healthcare providers to give parents or legal guardians full access to their minor child's electronic medical records (including online patient portals), except in three specific cases: 1) when the minor can legally consent to treatment without parents (e.g., certain reproductive or mental health services), 2) when a protective order or court ruling prohibits access, or 3) when a provider documents in writing that disclosure could cause abuse or neglect. This bill directly affects parents, guardians, and healthcare providers by changing how medical records are shared. It aims to support parental involvement in children’s healthcare decisions while preserving existing legal protections for minors in sensitive situations. The bill takes effect 60 days after enactment.
HB 1719 removes Hepatitis B from the list of diseases for which childhood immunization is required in New Hampshire. This change directly affects children enrolled in schools or childcare programs, as parents will no longer be required to ensure their children receive the Hepatitis B vaccine for enrollment. The bill amends state law by deleting "Hepatitis B" from the mandated immunization list, which includes diseases like measles and polio. This policy shift is expected to reduce state vaccine purchase costs by approximately $20,000 in the first year and $82,000 annually thereafter, as the requirement is eliminated. The Hepatitis B vaccine would remain available on a voluntary basis for parents who choose to use it.
SB 545 removes the asset limit (resource test) for New Hampshire's Medicare Savings Program, allowing seniors previously denied due to savings or assets to qualify. It also seeks federal approval to extend the low-income Medicare Part D subsidy, helping residents cover prescription drug costs. The bill directly affects approximately 2,033 additional seniors who were previously ineligible under the asset rule. This change would make program eligibility solely based on income, not savings or assets, with estimated annual state costs of $2.3 million from general funds.
SB 543 establishes provisional eligibility for Medicaid nursing facility services in New Hampshire, directly affecting long-term care applicants and nursing facilities. The bill requires the Department of Health and Human Services to grant temporary coverage within 90 days of application submission if a facility agrees to comply with program terms, without waiting for full application completion. This provisional status lasts up to 18 months or until a final eligibility decision, with facilities receiving payments during this period and required to reimburse funds if final approval is denied. The bill appropriates $1 for the 2026-2027 biennium to fund this program and creates two new positions within the department to manage it (per RSA 167:8).
HB 349 authorizes licensed optometrists who meet specific board-certification criteria to perform three eye laser procedures: laser capsulotomy, laser trabeculoplasty, and laser peripheral iridotomy. It directly affects optometrists seeking to expand their scope of practice, requiring them to complete approved education, training, and experience before performing these procedures. The bill mandates the Board of Registration in Optometry to establish rules for certification, including minimum training standards, proctoring requirements, and outcome reporting for these procedures. The law takes effect 60 days after passage, with no new state funding provided.
